状尿素在状细胞疾病中 现代时代 现代时代
Chazmyn Riley1, Walter K Kraft1, Robin Miller2
1Department of Pharmacology, Physiology and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA.
Expert review of clinical pharmacology
|August 13, 2024
概括
氧尿素仍然是状细胞疾病的基石治疗,有效地管理痛苦的危机和输血. 尽管有新的治疗方法,但它的负担能力和已证明的疗效巩固了它在综合疾病管理中的作用.
科学领域:
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
- 遗传学 遗传学 是一个
背景情况:
- 状细胞疾病 (SCD) 是一种遗传性血液疾病,导致红细胞聚合,血管封闭和血液溶解性贫血,导致严重的急性和慢性并发症.
- 全球有数百万人受到影响,特别是在撒哈拉以南非洲,这凸显了需要有效和可获得的治疗方法的需要.
- 氧尿素是FDA批准的SCD的第一个药物,主要用于减少严重疾病患者的痛苦危机和输血需要.
研究的目的:
- 审查当前的临床数据,安全信息和证据,支持基尿素在控制状细胞疾病中的作用.
- 根据新药批准,检查状细胞病的不断变化的治疗场景.
- 提供基尿素持续相关性和扩大研究领域的全面概述.
主要方法:
- 采用了叙事审查方法.
- 在PubMed和Cochrane图书馆数据库中进行了全面的文献搜索.
- 搜索涵盖了1963年至2024年的出版物,重点是状细胞疾病中的氧尿素.
主要成果:
- 氧尿素被公认为状细胞疾病的黄金标准治疗方法,即使有新药的出现.
- 它作为一种疾病修饰剂,具有额外的临床益处,其特点是可负担性和既定的安全性.
- 目前正在进行的研究正在探索氧尿素的不足利用和药物基因组学方面.
结论:
- 基尿素仍然是状细胞疾病管理中的重要治疗剂,因为它的有效性,安全性和成本效益.
- 它的长期记录支持其作为关键治疗选择的持续使用.
- 对其应用和个性化医疗方法进行广泛的研究是有必要的.
更多相关视频
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
1.7K
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
19.4K
相关概念视频
Bone Marrow Sampling and Transplants
317
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
317
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Multiple Allele Traits
34.1K
The Concept of Multiple Allelism
34.1K
Erythropoiesis
4.1K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.1K
Overview of Hematopoiesis
3.9K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
3.9K
